Term ends Nov 29, 2032 · Medium confidence
20-year base term ends Nov 29, 2032
Why Medium: A parent in the chain could not be resolved.
Held by Pharma Cinq, LLC
Filed Nov 14, 2014 as application 14/401,278 · Granted Apr 18, 2017
Base term, 20 years from filing
Today
2012
2032
Clock starts
Nov 29, 2012
Nov 29, 2012
Term ends
Nov 29, 2032
Nov 29, 2032
Granted
Apr 18, 2017
Apr 18, 2017
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 29, 2012, when application PCT/US2012/067041, the earliest non-provisional in its chain, was filed (this one was filed Nov 14, 2014); a parent in its chain could not be resolved (the next row) | Nov 29, 2032 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force (reinstated) | High confidence |
| Computed term end | The steps above, in order | Nov 29, 2032 | Medium confidence |
This family
| US 9,075,042 | Lapsed on the fee record Jul 2023 | Jul 2023 |
| US 9,081,001 | Lapsed on the fee record Jul 2023 | Jul 2023 |
| US 9,625,465 | this patent Nov 2032 | Nov 2032 |
| US 9,213,043 | In force Nov 2032 | Nov 2032 |
| US 10,716,887 | In force Jun 2033 | Jun 2033 |
5 of 9 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 21, 2016 Reel 41156, frame 44 | Wellstat Diagnostics, LLC | Defined Diagnostics, LLC | Change of Name |
| Jul 19, 2017 Reel 43252, frame 126 | Defined Diagnostics, LLC | PDL Biopharma, Inc. | Assignment of Assignor's Interest |
| Feb 16, 2021 Reel 55313, frame 842 | PDL Biopharma, Inc. | Defined Diagnostics, LLC (F/K/A Wellstat Diagnostics, LLC) | Assignment of Assignor's Interest |
| Jan 22, 2024 Reel 66203, frame 612 | Defined Diagnostics, LLC (F/K/A Wellstat Diagnostics, LLC) | Pharma Cinq, LLC | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 2032
Term ends Nov 29, 2032. Maintenance fees still fall due before then
Citations
5
later US patents cite this one
That is above the median of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.